Key facts
- Notable investors include Society for Innovation and Entrepreneurship, Leo Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Jeevatva Biosciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Jeevatva Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jeevatva Biosciences
Developer of microbiome-based therapeutic products intended to restore balance and functionality in the human microbiome. The company develops formulations composed of well-characterized microbial strains derived from healthy human microbiota and prebiotics, supported by safety and efficacy studies and manufactured in compliance with Good Manufacturing Practices, enabling healthcare and wellness applications to deliver evidence-based, quality-assured microbiome interventions.
- Sector
- Healthcare
- HQ
- Lucknow, India
- Founded
- 2023
- Website
- jeevatva.com/
- Ownership
- Privately Held (backing)
Jeevatva Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jeevatva Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jeevatva Biosciences in its N-PORT filings yet. We sweep new filings monthly.